AZ-话题@MedSci

#AZ#

260篇内容 | 4201人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1714889, encodeId=42d21e148899b, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Gastroenterology：基于Vonoprazan的三联疗法均可有效根除幽门螺杆菌, objectType=article, longId=201044, objectId=f0ae201044db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0ae201044db, replyNumber=0, likeNumber=60, createdTime=2021-03-30, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0ae201044db, moduleTitle=J Gastroenterology：基于Vonoprazan的三联疗法均可有效根除幽门螺杆菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0ae201044db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714905, encodeId=3f881e1490585, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Gastroenterology：基于Vonoprazan的三联疗法均可有效根除幽门螺杆菌, objectType=article, longId=207502, objectId=eeb020e50216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eeb020e50216, replyNumber=0, likeNumber=54, createdTime=2022-01-22, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eeb020e50216, moduleTitle=J Gastroenterology：基于Vonoprazan的三联疗法均可有效根除幽门螺杆菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eeb020e50216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714875, encodeId=4d261e1487549, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Otorhinolaryngol：刮除式腺样体切除术与内镜辅助下微创腺样体切除术在耳咽管功能障碍方面的比较, objectType=article, longId=196151, objectId=e42f1961512e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e42f1961512e, replyNumber=0, likeNumber=75, createdTime=2021-03-15, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e42f1961512e, moduleTitle=Braz J Otorhinolaryngol：刮除式腺样体切除术与内镜辅助下微创腺样体切除术在耳咽管功能障碍方面的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e42f1961512e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714862, encodeId=a5c91e1486241, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Zydus Cadila的PPAR激动剂saroglitazar在印度获批，用于治疗非酒精性脂肪性肝炎, objectType=article, longId=189572, objectId=17961895e2f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17961895e2f5, replyNumber=0, likeNumber=77, createdTime=2020-09-30, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17961895e2f5, moduleTitle=Zydus Cadila的PPAR激动剂saroglitazar在印度获批，用于治疗非酒精性脂肪性肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17961895e2f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714896, encodeId=df271e14896ee, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Br J Cancer：G3BP1与YWHAZ表达水平：胃癌化疗耐药性及疗效的预测指标, objectType=article, longId=201965, objectId=ab57201965f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab57201965f9, replyNumber=0, likeNumber=63, createdTime=2021-01-08, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab57201965f9, moduleTitle=Br J Cancer：G3BP1与YWHAZ表达水平：胃癌化疗耐药性及疗效的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab57201965f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Psychiatry：舌下含服和口服唑吡坦可有效治疗失眠症, objectType=article, longId=201697, objectId=4a5a20169ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a5a20169ece, replyNumber=0, likeNumber=74, createdTime=2021-04-20, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a5a20169ece, moduleTitle=Braz J Psychiatry：舌下含服和口服唑吡坦可有效治疗失眠症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a5a20169ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714871, encodeId=c6f41e148713e, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Genes Dev：研究揭示YAP/TAZ诱导AP-1有助于细胞增殖和器官生长, objectType=article, longId=194720, objectId=21f2194e2003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21f2194e2003, replyNumber=0, likeNumber=80, createdTime=2020-06-27, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21f2194e2003, moduleTitle=Genes Dev：研究揭示YAP/TAZ诱导AP-1有助于细胞增殖和器官生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21f2194e2003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714866, encodeId=b9361e1486674, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Dent J：阿奇霉素联合全口洁治治疗牙周炎的效果, objectType=article, longId=192556, objectId=6e371925562d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e371925562d, replyNumber=0, likeNumber=76, createdTime=2020-07-16, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e371925562d, moduleTitle=Braz Dent J：阿奇霉素联合全口洁治治疗牙周炎的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e371925562d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714899, encodeId=81cf1e148990d, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Acadia公司通过电影纪录片，为Nuplazid药物上市成功营销！, objectType=article, longId=202956, objectId=61a6202956bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61a6202956bb, replyNumber=0, likeNumber=76, createdTime=2021-04-10, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61a6202956bb, moduleTitle=Acadia公司通过电影纪录片，为Nuplazid药物上市成功营销！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61a6202956bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714864, encodeId=90701e1486422, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=CELL METAB：胆固醇稳定TAZ表达，促进非酒精性脂肪肝炎, objectType=article, longId=191731, objectId=515b191e3123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515b191e3123, replyNumber=0, likeNumber=70, createdTime=2021-02-25, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515b191e3123, moduleTitle=CELL METAB：胆固醇稳定TAZ表达，促进非酒精性脂肪肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=515b191e3123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714872, encodeId=c61d1e1487287, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Nat Commun：YAP/TAZ是纤维母细胞网状细胞承诺和成熟的关键调节剂, objectType=article, longId=194725, objectId=12ce194e2505, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12ce194e2505, replyNumber=0, likeNumber=79, createdTime=2021-04-05, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12ce194e2505, moduleTitle=Nat Commun：YAP/TAZ是纤维母细胞网状细胞承诺和成熟的关键调节剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12ce194e2505)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714857, encodeId=27b41e148578b, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Gastroenterology：沃诺拉赞（Vonoprazan）的使用综述, objectType=article, longId=187357, objectId=5bb618e35727, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bb618e35727, replyNumber=0, likeNumber=80, createdTime=2020-02-15, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bb618e35727, moduleTitle=Gastroenterology：沃诺拉赞（Vonoprazan）的使用综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bb618e35727)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714855, encodeId=0a351e1485595, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=加拿大卫生部批准Drax Exametazime用于核医学成像, objectType=article, longId=186911, objectId=42d8186911ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42d8186911ac, replyNumber=0, likeNumber=64, createdTime=2020-08-16, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42d8186911ac, moduleTitle=加拿大卫生部批准Drax Exametazime用于核医学成像, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42d8186911ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714885, encodeId=88451e148853b, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=抗体药物偶联物[Vic-]曲妥珠单抗 Duocarmazine治疗HER2阳性实体瘤：已启动I期临床研究, objectType=article, longId=199921, objectId=e4ad199921fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ad199921fd, replyNumber=0, likeNumber=69, createdTime=2020-09-14, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ad199921fd, moduleTitle=抗体药物偶联物[Vic-]曲妥珠单抗 Duocarmazine治疗HER2阳性实体瘤：已启动I期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ad199921fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714874, encodeId=408b1e1487419, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=UCB以2.7亿美元收购Engage公司，及其手持口腔吸入式癫痫急救药物Staccato Alprazolam, objectType=article, longId=195460, objectId=3cd41954601e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cd41954601e, replyNumber=0, likeNumber=65, createdTime=2020-10-22, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cd41954601e, moduleTitle=UCB以2.7亿美元收购Engage公司，及其手持口腔吸入式癫痫急救药物Staccato Alprazolam, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cd41954601e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714897, encodeId=828a1e148974f, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Regeneron的Inmazeb成为获得FDA批准的埃博拉病毒治疗药物, objectType=article, longId=202130, objectId=a6d020213007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6d020213007, replyNumber=0, likeNumber=91, createdTime=2021-04-29, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6d020213007, moduleTitle=Regeneron的Inmazeb成为获得FDA批准的埃博拉病毒治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6d020213007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714892, encodeId=0f7e1e14892fe, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, objectType=article, longId=201355, objectId=2779201355ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2779201355ed, replyNumber=0, likeNumber=72, createdTime=2021-01-12, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2779201355ed, moduleTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2779201355ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714868, encodeId=87341e148684b, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移, objectType=article, longId=192934, objectId=0ff21929347b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ff21929347b, replyNumber=0, likeNumber=78, createdTime=2020-08-26, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ff21929347b, moduleTitle=J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ff21929347b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714851, encodeId=f6291e1485138, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Leriglitazone治疗Friedreich共济失调：已获欧洲委员会的孤儿药认定, objectType=article, longId=182982, objectId=f801182982f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f801182982f8, replyNumber=0, likeNumber=64, createdTime=2020-07-17, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f801182982f8, moduleTitle=Leriglitazone治疗Friedreich共济失调：已获欧洲委员会的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f801182982f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714878, encodeId=3a7a1e1487808, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Psychiatry：舌下和口服唑吡坦治疗失眠症的疗效, objectType=article, longId=196527, objectId=80cc19652eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80cc19652eb0, replyNumber=0, likeNumber=88, createdTime=2021-04-01, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80cc19652eb0, moduleTitle=Braz J Psychiatry：舌下和口服唑吡坦治疗失眠症的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80cc19652eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

AZ

2020-05-29

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Gastroenterology：基于Vonoprazan的三联疗法均可有效根除幽门螺杆菌

2021-03-30

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Gastroenterology：基于Vonoprazan的三联疗法均可有效根除幽门螺杆菌

2022-01-22

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Otorhinolaryngol：刮除式腺样体切除术与内镜辅助下微创腺样体切除术在耳咽管功能障碍方面的比较

2021-03-15

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Zydus Cadila的PPAR激动剂saroglitazar在印度获批，用于治疗非酒精性脂肪性肝炎

2020-09-30

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Br J Cancer：G3BP1与YWHAZ表达水平：胃癌化疗耐药性及疗效的预测指标

2021-01-08

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Psychiatry：舌下含服和口服唑吡坦可有效治疗失眠症

2021-04-20

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Genes Dev：研究揭示YAP/TAZ诱导AP-1有助于细胞增殖和器官生长

2020-06-27

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Dent J：阿奇霉素联合全口洁治治疗牙周炎的效果

2020-07-16

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Acadia公司通过电影纪录片，为Nuplazid药物上市成功营销！

2021-04-10

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

CELL METAB：胆固醇稳定TAZ表达，促进非酒精性脂肪肝炎

2021-02-25

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Nat Commun：YAP/TAZ是纤维母细胞网状细胞承诺和成熟的关键调节剂

2021-04-05

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Gastroenterology：沃诺拉赞（Vonoprazan）的使用综述

2020-02-15

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

加拿大卫生部批准Drax Exametazime用于核医学成像

2020-08-16

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

抗体药物偶联物[Vic-]曲妥珠单抗 Duocarmazine治疗HER2阳性实体瘤：已启动I期临床研究

2020-09-14

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

UCB以2.7亿美元收购Engage公司，及其手持口腔吸入式癫痫急救药物Staccato Alprazolam

2020-10-22

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Regeneron的Inmazeb成为获得FDA批准的埃博拉病毒治疗药物

2021-04-29

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Derazantinib治疗晚期胃癌：即将开展I/II期研究

2021-01-12

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移

2020-08-26

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Leriglitazone治疗Friedreich共济失调：已获欧洲委员会的孤儿药认定

2020-07-17

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Psychiatry：舌下和口服唑吡坦治疗失眠症的疗效

2021-04-01

科室
- - 订阅+
  - 更多科室
工具
服务